U.S. Pharmaceutical Sales - Q3 2011
The following is a list of the top 100 prescribed medicines by US National Sales in Q3 2011. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q3 2011 by units sold
Rank |
Drug |
Units (000) |
|
|
1 |
acetaminophen/hydrocodone Generic |
9,396 |
-2.04% |
Stats |
2 ( 2) |
budesonide Generic |
9,031 |
25.08% |
Stats |
3 ( 3) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
7,389 |
4.51% |
Stats |
4 ( 2) |
Nexium AstraZeneca |
7,119 |
-4.78% |
Stats |
5 |
OneTouch
|
6,961 |
-2.58% |
Stats |
6 ( 3) |
Singulair Merck |
6,668 |
-10.40% |
Stats |
7 |
Lipitor
|
6,297 |
-3.00% |
Stats |
8 ( 1) |
Lantus Sanofi |
5,953 |
-1.70% |
Stats |
9 ( 1) |
Cymbalta
|
5,858 |
-1.53% |
Stats |
10 ( 2) |
Advair Diskus GlaxoSmithKline |
5,685 |
-6.71% |
Stats |
11 |
Plavix
|
5,318 |
-2.58% |
Stats |
12 |
fentanyl Generic |
4,455 |
-2.50% |
Stats |
13 |
AndroGel AbbVie Inc. |
4,102 |
-8.93% |
Stats |
14 |
Crestor AstraZeneca |
3,897 |
-0.46% |
Stats |
15 ( 3) |
Lantus Solostar Sanofi |
3,252 |
6.00% |
Stats |
16 ( 1) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,140 |
-2.45% |
Stats |
17 ( 2) |
Novolog Novo Nordisk |
2,887 |
-2.66% |
Stats |
18 ( 1) |
Actos Takeda Pharmaceutical Company Limited |
2,735 |
-12.03% |
Stats |
19 ( 4) |
Synthroid AbbVie Inc. |
2,712 |
6.60% |
Stats |
20 ( 1) |
Humalog Eli Lilly and Company |
2,600 |
-1.78% |
Stats |
21 ( 1) |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,499 |
-2.54% |
Stats |
22 ( 2) |
Nasonex Merck |
2,476 |
-16.18% |
Stats |
23 ( 2) |
Levemir Novo Nordisk |
2,411 |
4.10% |
Stats |
24 |
metoprolol Generic |
2,376 |
-5.94% |
Stats |
25 ( 1) |
Lexapro Allergan plc |
2,177 |
-5.92% |
Stats |
26 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
2,104 |
-8.44% |
Stats |
27 ( 8) |
NovoLog FlexPen Novo Nordisk |
2,049 |
4.92% |
Stats |
28 ( 4) |
Januvia Merck |
2,044 |
0.79% |
Stats |
29 ( 1) |
Namenda Allergan plc |
2,026 |
-2.27% |
Stats |
30 ( 1) |
Lyrica
|
2,007 |
-2.10% |
Stats |
31 ( 2) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
1,974 |
-6.36% |
Stats |
32 ( 1) |
Zetia Merck |
1,946 |
-4.00% |
Stats |
33 ( 6) |
Suboxone
|
1,792 |
3.23% |
Stats |
34 ( 2) |
Seroquel AstraZeneca |
1,727 |
-5.73% |
Stats |
35 ( 2) |
Flovent HFA GlaxoSmithKline |
1,655 |
-9.36% |
Stats |
36 ( 9) |
enoxaparin Generic |
1,585 |
4.41% |
Stats |
37 ( 6) |
Lidoderm Endo Pharmaceuticals Inc. |
1,573 |
-1.63% |
Stats |
38 ( 6) |
Remicade Janssen Pharmaceuticals, Inc. |
1,568 |
1.03% |
Stats |
39 ( 1) |
Lovaza GlaxoSmithKline |
1,565 |
-8.75% |
Stats |
40 ( ) |
Fluvirin Seqirus |
1,533 |
n/a |
Stats |
41 |
Vytorin Merck |
1,516 |
-10.72% |
Stats |
42 |
Benicar Daiichi Sankyo |
1,512 |
-5.85% |
Stats |
43 ( 3) |
Symbicort AstraZeneca |
1,490 |
0.27% |
Stats |
44 ( 3) |
Zyprexa
|
1,361 |
-7.60% |
Stats |
45 ( 3) |
Diovan HCT Novartis Pharmaceuticals Corporation |
1,320 |
-7.76% |
Stats |
46 ( 3) |
OxyContin Purdue Pharma LP |
1,301 |
-4.69% |
Stats |
47 ( 3) |
Restasis Allergan plc |
1,282 |
-1.16% |
Stats |
48 ( 4) |
Lovenox Sanofi |
1,138 |
-7.70% |
Stats |
49 ( 2) |
Niaspan AbbVie Inc. |
1,130 |
-10.46% |
Stats |
50 ( 3) |
Celebrex
|
1,018 |
-4.32% |
Stats |
51 ( 3) |
TriCor AbbVie Inc. |
959 |
-4.39% |
Stats |
52 ( 4) |
VESIcare Astellas Pharma US, Inc. |
944 |
-0.84% |
Stats |
53 ( 2) |
Evista
|
924 |
-4.25% |
Stats |
54 ( 6) |
Janumet Merck |
868 |
1.52% |
Stats |
55 ( 3) |
Enbrel Amgen Inc. |
848 |
-2.97% |
Stats |
56 ( 1) |
Aciphex Eisai Inc. |
845 |
-10.77% |
Stats |
57 ( ) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
816 |
n/a |
Stats |
58 ( 4) |
Geodon
|
712 |
-3.65% |
Stats |
59 ( 4) |
Vyvanse Takeda Pharmaceutical Company Limited |
671 |
1.51% |
Stats |
60 ( 1) |
Epogen Amgen Inc. |
647 |
-18.41% |
Stats |
61 ( 3) |
Rebif EMD Serono, Inc. |
596 |
-1.49% |
Stats |
62 ( 15) |
methylphenidate Generic |
593 |
40.86% |
Stats |
63 ( 2) |
amphetamine/dextroamphetamine Generic |
590 |
2.25% |
Stats |
64 ( 2) |
Cialis Eli Lilly and Company |
558 |
2.01% |
Stats |
65 ( 4) |
Humira AbbVie Inc. |
548 |
3.01% |
Stats |
66 ( 2) |
Truvada Gilead Sciences, Inc. |
543 |
1.69% |
Stats |
67 |
Rituxan Genentech, Inc. |
527 |
-1.86% |
Stats |
68 ( 2) |
Provigil
|
522 |
1.16% |
Stats |
69 ( 6) |
Atripla Gilead Sciences, Inc. |
460 |
0.88% |
Stats |
70 ( 2) |
Avastin Genentech, Inc. |
454 |
-3.61% |
Stats |
71 ( 3) |
Seroquel XR AstraZeneca |
450 |
-1.96% |
Stats |
72 ( 1) |
Viagra
|
450 |
-3.64% |
Stats |
73 ( 10) |
Varivax Merck |
417 |
42.81% |
Stats |
74 ( 2) |
Adderall XR Takeda Pharmaceutical Company Limited |
392 |
-10.30% |
Stats |
75 ( 4) |
Lunesta Sunovion Pharmaceuticals Inc. |
368 |
-2.39% |
Stats |
76 ( 4) |
Aranesp Amgen Inc. |
330 |
-11.29% |
Stats |
77 ( 5) |
Neulasta Amgen Inc. |
315 |
-5.69% |
Stats |
78 ( 7) |
Solodyn Medicis Pharmaceutical Corporation |
310 |
16.10% |
Stats |
79 ( 1) |
Procrit Janssen Pharmaceuticals, Inc. |
299 |
-21.32% |
Stats |
80 ( 6) |
docetaxel Generic |
282 |
6.02% |
Stats |
81 ( 3) |
Reyataz Bristol-Myers Squibb Company |
280 |
-1.75% |
Stats |
82 ( 5) |
Erbitux Eli Lilly and Company |
254 |
-1.93% |
Stats |
83 ( 9) |
Eloxatin Sanofi |
236 |
29.67% |
Stats |
84 ( 4) |
Lucentis Genentech, Inc. |
232 |
0.87% |
Stats |
85 ( 4) |
Copaxone Teva Pharmaceuticals USA, Inc. |
227 |
-0.44% |
Stats |
86 ( 4) |
Isentress Merck |
225 |
2.74% |
Stats |
87 ( ) |
Opana ER Endo Pharmaceuticals Inc. |
214 |
n/a |
Stats |
88 ( 3) |
Zometa Novartis Pharmaceuticals Corporation |
199 |
-4.78% |
Stats |
89 ( ) |
Prezista Janssen Pharmaceuticals, Inc. |
185 |
n/a |
Stats |
90 ( ) |
Prevnar 13 Pfizer Inc. |
178 |
n/a |
Stats |
91 ( 2) |
Alimta Eli Lilly and Company |
169 |
-0.59% |
Stats |
92 ( 2) |
Neupogen Amgen Inc. |
158 |
0.64% |
Stats |
93 ( 3) |
Herceptin Genentech, Inc. |
148 |
-0.67% |
Stats |
94 ( 1) |
Zyvox Pfizer Inc. |
140 |
-9.68% |
Stats |
95 ( 2) |
Avonex Biogen |
138 |
-1.43% |
Stats |
96 ( 2) |
Velcade Takeda Pharmaceutical Company Limited |
136 |
1.49% |
Stats |
97 ( 2) |
Gleevec Novartis Pharmaceuticals Corporation |
83 |
-2.35% |
Stats |
98 ( 2) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
79 |
-2.47% |
Stats |
99 ( ) |
Xeloda Genentech, Inc. |
69 |
n/a |
Stats |
100 ( ) |
Incivek Vertex Pharmaceuticals Incorporated |
22 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.